大健康国际中期报告2025/2026

Stock Code: 2211(Incorporated in the Cayman Islands with limited liability CORPORATE INFORMATION公司資料 BOARD OF DIRECTORS 董事會 執行董事： Executive Directors: Mr. Chu Chuanfu(Chairman, Chief Executive Officer andChief Operation Officer)Mr. Jin Dongkun(Vice Chairman)Mr. Zhao Zehua 獨立非執行董事： Independent Non-executive Directors: Mr. Cheng Sheung HingMs. Chiang Su Hui SusieMr. Zou Haiyan AUDIT COMMITTEE 審核委員會 Mr. Zou Haiyan(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie REMUNERATION COMMITTEE 薪酬委員會 Mr. Cheng Sheung Hing(Chairman)Ms. Chiang Su Hui SusieMr. Jin Dongkun NOMINATION COMMITTEE 提名委員會 Mr. Chu Chuanfu(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie 綠色可持續發展委員會 ESG COMMITTEE Mr. Chu Chuanfu(Chairman)Mr. Cheng Sheung HingMs. Chiang Su Hui Susie 授權代表 AUTHORISED REPRESENTATIVES Ms. Hui Kit YingMr. Zhao Zehua 公司秘書 COMPANY SECRETARYMs. Hui Kit Ying Universal Health International Group Holding LimitedInterim Report 2025/26 註冊辦事處 REGISTERED OFFICE PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands PO Box 309Ugland HouseGrand Cayman, KY1-1104Cayman Islands 總部 HEADQUARTERS 14-1 No. 14-1Bei Yi Zhong RoadTiexi DistrictShenyang CityLiaoning Province, the PRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 香港主要營業地點 19242404 Room 2404, 24th FloorWorld-Wide House19 Des Voeux Road CentralCentralHong Kong 主要股份過戶登記處 PRINCIPAL SHARE REGISTRAR AND TRANSFEROFFICE Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands 香港股份過戶登記處 HONG KONG SHARE REGISTRAR AND TRANSFEROFFICE 香港中央證券登記有限公司 Computershare Hong Kong Investor Services Limited 183171712-1716 Shops 1712-171617th Floor, Hopewell Centre183 Queen’s Road EastWanchai, Hong Kong AUDITOR 核數師 1842 Forvis Mazars CPA LimitedCertified Public Accountants andRegistered Public Interest Entity Auditor42nd Floor, Central Plaza18 Harbour RoadWanchaiHong Kong 股份代號2211 STOCK CODEThe Main Board of The Stock Exchange ofHong Kong Limited: 2211 投資者關係ir@uhi-group.com INVESTOR RELATIONSir@uhi-group.com 公司網站www.uhighl.com COMPANY’S WEBSITEwww.uhighl.com Universal Health International Group Holding LimitedInterim Report 2025/26 Notes: 1.2.110,546,21880,105,9563.4.5.6. 1.Adjusted EBITDA is calculated by adjusted loss before interests, tax, depreciation andamortisation, excluding the effect of share of post-tax results of an associate, impairmentloss or, if applicable, its reversal on intangible assets, property, plant and equipment,right-of-use assets and investment in an associate.2.Basic loss per share is calculated by dividing loss attributable to owners of the Companyby weighted average number of ordinary shares in issue (the weighted average numberof ordinary shares in issue of the Company for the six months ended 31 December 2025was 110,546,218, versus 80,105,956 (restated), for the six months ended 31 December2024).The basic loss per share for the six months ended 31 December 2024 has been restatedto reflect the share consolidation effected during the year ended 30 June 2025.3.Current ratio is calculated by dividing current assets by current liabilities.4.Trade receivables turnover days are calculated by using the average of beginning andending balances on trade receivables for the period, divided by revenue for the period,multiplied by the number of days for the period.5.Inventory turnover days are calculated by using the average of beginning and endingbalances on inventory for the period, divided by cost of sales for the period, multipliedby the number of days for the period.6.Trade payables turnover days are calculated by using the average of beginning andending balances on trade payables for the period, divided by cost of sales for the period,multiplied by the number of days for the period. MANAGEMEN T DISCUSSION AND ANALYSIS管理層討論及分析 The board (the “Board”) of directors (the “Directors”) of UniversalHealth International Group Holding Limited (the “Company”,together with its subsidiaries, the “Group”) is pleased to announcethe unaudited interim results of the Group for the six months ended31 December 2025 (the “Period”) together with the comparativefigures for the corresponding period in 2024. 行業概覽 INDUSTRY OVERVIEW 2025 Entering the second half of 2025, China’s healthcare industrystood at the convergence of policy refinements, technologicalbreakthroughs, and evolving demands, exhibiting a developmentlandscape characterized by both structural growth and long-termresilience. Spanning multiple sectors including medical services,pharmaceuticalproducts,elderly care,health management,rehabilitation equipment, nutritional foods, and smart healthtechnologies, the healthcare industry has transformed from atraditional supplementary healthcare industry to a vital strategicindustry underpinning national health and economic growth. 60 Froma macro perspective